Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP (Swe) /PS1ΔE9 Transgenic Female Mice

Alzheimer’s disease (AD) is a neurodegenerative disease that causes behavioral and cognitive impairments. The phytocannabinoid cannabidiol (CBD) has anti-inflammatory, antioxidant, and neuroprotective properties, and in vitro and limited in vivo evidence suggests that CBD possesses therapeutic-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Coles, Madilyn, Watt, Georgia, Kreilaus, Fabian, Karl, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789874/
https://www.ncbi.nlm.nih.gov/pubmed/33424597
http://dx.doi.org/10.3389/fphar.2020.587604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789874/
https://www.ncbi.nlm.nih.gov/pubmed/33424597
http://dx.doi.org/10.3389/fphar.2020.587604

Ejemplares similares